Compounds > hypericin

hypericin and paclitaxel

hypericin has been researched along with paclitaxel in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Schempp, CM; Simon, JC; Simon-Haarhaus, B; Termeer, CC1
Agostinis, P; Assefa, Z; De Witte, PA; Merlevede, W; Piette, J; Vandenheede, JR; Vantieghem, A; Xu, Y1
Cao, H; Cui, X; Guo, H; Han, C; Li, Y; Wang, S; Xi, X; Xu, F; Zheng, M1

Reviews

1 review(s) available for hypericin and paclitaxel

ArticleYear
Yield enhancement strategies of rare pharmaceutical metabolites from endophytes.
    Biotechnology letters, 2018, Volume: 40, Issue:5

    Topics: Anthracenes; DNA Shuffling; Endophytes; Fermentation; Industrial Microbiology; Limonins; Metabolome; Paclitaxel; Perylene; Plants; Podophyllotoxin

2018

Other Studies

4 other study(ies) available for hypericin and paclitaxel

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
    FEBS letters, 2001, Mar-23, Volume: 493, Issue:1

    Topics: Anthracenes; Antibodies, Monoclonal; Antigens, CD; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Division; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; In Situ Nick-End Labeling; Jurkat Cells; Light; Membrane Glycoproteins; Oligopeptides; Paclitaxel; Perylene; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2001
Phosphorylation of Bcl-2 in G2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis.
    The Journal of biological chemistry, 2002, Oct-04, Volume: 277, Issue:40

    Topics: Anthracenes; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; G2 Phase; HeLa Cells; Humans; Kinetics; Mitosis; Nocodazole; Paclitaxel; Perylene; Photochemotherapy; Protein Kinase C; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Vinblastine

2002